New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
393-419
Author(s):
Christian Hafner, Albrecht Reichle and Thomas Vogt
Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
445-455
Author(s):
Daruka Mahadevan and Nikhil Shirahatti
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Journal:
Current Drug Targets
Volume:
6
Page:
665-682
Author(s):
K. Fjeldstad and S. O. Kolset
Genetic Susceptibility to Risk for Bladder Cancer in Individuals Working in High Risk Occupations
Journal:
Current Pharmacogenomics
Volume:
3
Page:
165-175
Author(s):
Robert A. Branch, Nancy Paulsen, Raj A. Persad, Patrick J.B. Smith, Christopher Collins, Ann Schwartz, Al Cecchetti, Vincent C. Arena, Kendra Jones and Marjorie Romkes
Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
431-447
Author(s):
S. M. Cutts, L. P. Swift, A. Rephaeli, A. Nudelman and D. R. Phillips
Transcriptionally Targeted Adenovirus Vectors
Journal:
Current Gene Therapy
Volume:
5
Page:
411-427
Author(s):
Hamid Sadeghi and Mary M. Hitt
The Use of Oncolytic Vaccinia Viruses in the Treatment of Cancer: A New Role for an Old Ally?
Journal:
Current Gene Therapy
Volume:
5
Page:
429-443
Author(s):
Stephen H. Thorne, David L. Bartlett and David H. Kirn
Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
2075-2094
Author(s):
Mathea Sophia Galanski*, Michael A. Jakupec and Bernhard K. Keppler
Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2825-2840
Author(s):
F. M. Coppelli and J. R. Grandis
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
325-344
Author(s):
Marina A. Dobrovolskaia and Serguei V. Kozlov